APA (7th ed.) Citation

Shiozawa, M., Chang, C., Huang, Y., Chen, Y., Chi, M., Hao, H., . . . Wang, Y. (2018). Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells. BMC Immunology, 19(1), N.PAG. https://doi.org/10.1186/s12865-018-0262-z

Chicago Style (17th ed.) Citation

Shiozawa, Masayuki, et al. "Pharmacologically Upregulated Carcinoembryonic Antigen-expression Enhances the Cytolytic Activity of Genetically-modified Chimeric Antigen Receptor NK-92MI Against Colorectal Cancer Cells." BMC Immunology 19, no. 1 (2018): N.PAG. https://doi.org/10.1186/s12865-018-0262-z.

MLA (9th ed.) Citation

Shiozawa, Masayuki, et al. "Pharmacologically Upregulated Carcinoembryonic Antigen-expression Enhances the Cytolytic Activity of Genetically-modified Chimeric Antigen Receptor NK-92MI Against Colorectal Cancer Cells." BMC Immunology, vol. 19, no. 1, 2018, p. N.PAG, https://doi.org/10.1186/s12865-018-0262-z.